Skip to content

002626.SZ

Xiamen Kingdomway Group Co.

SZSE · Healthcare · C 制造业 · CN

CNY 18.10
+0.61%
Ask drillr

Year over year

Reported trailing growth

Revenue
+0.8%
EBITDA
—
EBIT
-42.6%
EPS
-26.9%
Free cash flow
-26.4%
Operating cash flow
-9.7%

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
+3.8%
EBITDA
+4.2%
EBIT
+6.7%
Net income
+9.7%
EPS
+10.1%
Free cash flow
-15.1%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026